Abstract:Background: The relationship between antibody levels (more generally, a scalar measure of immune protection) at the time of exposure to infection (so-called exposure-proximal correlates of protection) and the risk of infection given exposure is of central interest in evaluating the evolution of immune protection conferred by prior infection and/or vaccination. A version of the test-negative study design (TND), adapted from vaccine effectiveness studies, has been used to assess this relationship. However, the conditions under which such a study identifies the relationship between immune measurements and protection have not been defined. Objective: To evaluate the conditions for TNDs to estimate the relationship between antibody levels or a similar scalar measurement of immunity (hereafter exposure-proximal correlates of protection, COP) and the relative incidence rate of infection given exposure. Method: Individual-based transmission models, linking infection risk linearly and nonlinearly with COP value and accounting for waning immunity post-vaccination and -infection, were used. Simulations were performed of a TND with sampling on predetermined dates. Data from either one or multiple simulation days were analyzed using logistic regression and generalized additive models. Result: A correctly specified logistic regression model provided an unbiased estimate of the effectiveness of specific COP levels (analogous to vaccine effectiveness). Aggregating data across different simulation dates with incidence-density sampling also provided reliable estimates of protection. When, as is generally the case, the functional form relating COP level to protection is unknown, generalized additive models offer a more flexible alternative to traditional logistic regression approaches. Conclusion: A TND can validly estimate the relative effect of an immune COP at the time of exposure on the incidence rate of infection via logistic regression if the functional form of the effect is known and appropriately modeled or unknown a semiparametric approach. Future research should further examine the dynamics of immunity waning and boosting for more reliable inference.

Adjustment for Disease Severity in the Test-Negative Study Design

Severity-dependent test-seeking behaviors and test-negative designs: impact on estimated vaccine effectiveness and utility of analytic and design choices

Sensitivity Analysis for the Test-Negative Design

Potential Biases in Test-Negative Design Studies of COVID-19 Vaccine Effectiveness Arising from the Inclusion of Asymptomatic Individuals

Double Negative Control Inference in Test-Negative Design Studies of Vaccine Effectiveness

Test-negative designs with various reasons for testing: statistical bias and solution

Inference of Naturally Acquired Immunity Using a Self-matched Negative-Control Design

Test negative design for vaccine effectiveness estimation in the context of the COVID-19 pandemic: A systematic methodology review

Impact of unequal testing on vaccine effectiveness estimates across two study designs: a simulation study

Improved Methods for Vaccine Effectiveness Studies

Investigating confounding in network-based test-negative design influenza vaccine effectiveness studies-Experience from the DRIVE project

The test-negative design with additional population controls: a practical approach to rapidly obtain information on the causes of the SARS-CoV-2 epidemic

Use of the test-negative design to estimate the protective effect of a scalar immune measure: A simulation analysis

Randomization for the susceptibility effect of an infectious disease intervention

Bias in control selection associated with the use of rapid tests in influenza vaccine effectiveness studies

Alternative observational designs to estimate the effectiveness of one dose of oral cholera vaccine in Lusaka, Zambia

TNDDR: Efficient and doubly robust estimation of COVID-19 vaccine effectiveness under the test-negative design

Assessing effects of cholera vaccination in the presence of interference

Inference for a test-negative case-control study with added controls

Adaptive Group Testing with Mismatched Models